Fluidx Medical Technology Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

Fluidx Medical Technology General Information

Description

Developer of an embolic device designed for vascular occlusion. The company's technology utilizes an ionic gel platform that functions without toxic precursors or specialized mixing equipment, enabling healthcare providers to achieve precise vessel occlusion across interventional oncology and neurovascular applications.

Contact Information

Website
www.fluidxmedical.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2500 South State Street
  • Suite 246
  • Salt Lake City, UT 84115
  • United States
+1 (435)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 2500 South State Street
  • Suite 246
  • Salt Lake City, UT 84115
  • United States
+1 (435)

Fluidx Medical Technology Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Fluidx Medical Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 06-Aug-2026 Completed Clinical Trials - General
7. Later Stage VC (Series A) 02-May-2024 Completed Clinical Trials - General
6. Secondary Transaction - Private 14-Jun-2023 Completed Clinical Trials - General
5. Later Stage VC (Series A) 17-Mar-2023 Completed Clinical Trials - General
4. Seed Round 17-Mar-2023 Completed Clinical Trials - General
3. Grant 14-Jul-2016 Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Jan-2015 Completed Startup
To view Fluidx Medical Technology’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Fluidx Medical Technology Patents

  • 31

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 16

    Pending

  • Expiring in next 12 mo

Fluidx Medical Technology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026177925-A1 Injectable compositions composed of a statin, an anti-cancer agent, or a combination thereof for reducing or preventing blood flow in a neurovascular vessel Pending 24-Feb-2025
WO-2026177924-A1 Injectable compositions for reducing or preventing blood flow in a neurovascular vessel Pending 24-Feb-2025
AU-2024348490-A1 Use of in situ solidifying injectable compositions for filling a void in a subject Pending 25-Sep-2023
EP-4766412-A1 Use of in situ solidifying injectable compositions for filling a void in a subject Pending 25-Sep-2023
US-20260224774-A1 Use of in situ solidifying injectable compositions for filling a void in a subject Pending 25-Sep-2023 A61L27/18
To view Fluidx Medical Technology’s complete patent history, request access »

Fluidx Medical Technology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fluidx Medical Technology Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Neuroceuticals Venture Capital Minority
MedMountain Ventures Venture Capital Minority
Merit Medical Systems Corporation Minority
Utah Governor's Office of Economic Development Government Minority
University of Utah University
To view Fluidx Medical Technology’s complete investors history, request access »

Ready to get started?

Request a free trial

Fluidx Medical Technology FAQs

  • When was Fluidx Medical Technology founded?

    Fluidx Medical Technology was founded in 2015.

  • Where is Fluidx Medical Technology headquartered?

    Fluidx Medical Technology is headquartered in Salt Lake City, UT.

  • What is the size of Fluidx Medical Technology?

    Fluidx Medical Technology has 6 total employees.

  • What industry is Fluidx Medical Technology in?

    Fluidx Medical Technology’s primary industry is Therapeutic Devices.

  • Is Fluidx Medical Technology a private or public company?

    Fluidx Medical Technology is a Private company.

  • What is Fluidx Medical Technology’s current revenue?

    The current revenue for Fluidx Medical Technology is .

  • How much funding has Fluidx Medical Technology raised over time?

    Fluidx Medical Technology has raised $14.3M.

  • Who are Fluidx Medical Technology’s investors?

    Neuroceuticals, MedMountain Ventures, Merit Medical Systems, Utah Governor's Office of Economic Development, and University of Utah have invested in Fluidx Medical Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process